Liver and Bile

Clin Gastroenterol Hepatol. 2023;21(1):103–14.e10

Sharma R, Simon TG, Stephansson O, Verna EC, Emond J, Söderling J, Roelstraete B, Hagström H, Ludvigsson JF

Pregnancy outcomes in women with autoimmune hepatitis - A nationwide population-based cohort study with histopathology


Background and aims: Autoimmune hepatitis (AIH) is a chronic inflammatory liver condition that predominantly affects women. However, pregnancy risks remain unclear.
Methods: A nationwide population-based cohort study (ESPRESSO) in Sweden from 1992 to 2016 including 309 singleton births in women with AIH and 1532 matched births in women from the general population was performed. AIH was diagnosed as a combination of administrative coding from medical diagnosis of AIH and liver biopsy data from Sweden’s 28 pathology departments. Using conditional logistic regression, odds ratios (ORs) for adverse pregnancy outcomes were determined.
Results: Among 306 live births to women with AIH, 51 (16.7%) were preterm, compared with 70 of 1524 (4.6%) reference births. This corresponded to an OR of 5.10 for preterm birth (95% confidence interval [CI]: 3.29–7.92), with similar odds using sibling comparators. Women with AIH with and without cirrhosis had similar odds for preterm birth. The AIH association was particularly strong with medically indicated preterm birth (OR = 13.01; 95% CI: 5.50–30.79). AIH was associated with low birth weight (OR = 5.31; 95% CI: 2.82–9.99) and low 5-minute Apgar score (OR = 3.46; 95% CI: 1.14–10.49) offspring, but no association with congenital malformations (OR = 1.14; 95% CI: 0.68–1.91), small for gestational age (OR = 1.04; 95% CI: 0.38–2.85), stillbirth (OR = 0.59; 95% CI: 0.02–18.88), or neonatal death (OR = 7.42; 95% CI: 0.65–84.25) was found. Maternal AIH was linked to an increased odds of cesarean section (OR = 1.44; 95% CI: 1.04–2.00) and pre-eclampsia (OR = 3.65; 95% CI: 2.01–6.64), but not to gestational diabetes.

Conclusions: Maternal autoimmune hepatitis (AIH) was associated with a 5-fold higher odds of preterm birth, and cirrhosis at diagnosis did not add to the impact of AIH on preterm birth. Future studies are needed to understand how to reduce this risk.

Prof. Dr. J.F. Ludvigsson, Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden,
E-Mail: jonasludvigsson@yahoo.com

DOI: DOI: 10.1016/j.cgh.2021.12.024

Back to overview

this could be of interest:

Incidence and factors predictive of recurrent thrombosis in people with non-cirrhotic portal vein thrombosis

J Hepatol. 2023;78(1):114–22

Retreatment with immune checkpoint inhibitors after a severe immune-related hepatitis: Results from a prospective multicenter study

Clin Gastroenterol Hepatol. 2023;21(3):732–40

More articles on the topic